Clinical Trial Update: GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

View source ↗

Summary

An NIAID-sponsored GAS Epi study evaluating age-related antibody responses to the J8 vaccine against Group A Streptococcus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• J8 vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Streptococcus Group A | Status: COMPLETED